InvestorsHub Logo
Followers 45
Posts 2387
Boards Moderated 0
Alias Born 08/09/2016

Re: Whalatane post# 150083

Tuesday, 10/16/2018 5:48:33 PM

Tuesday, October 16, 2018 5:48:33 PM

Post# of 423489
Kiwi - I think you are getting the short end of the efficacy vs. cost (to Kaiser) stick. Any reasonable MD would prescribe a low risk drug like V to a person with your risk profile. Key issue is they also have to pay for it, which they don't want to do. Hopefully you win this argument after Nov. 10.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News